1 刘欣欣,马西元,缪美琪,等.IL-6及其受体在乳腺癌治疗中的作用研究进展[J].实用肿瘤学杂志,2023,37(2):149-154. 2 Dolina JS,Van Braeckel-Budimir N,Thomas GD,et al.CD8+T cell exhaustion in cancer[J].Front Immunol,2021,12:715234. 3 秦双,董良鹏,白宾,等.Toll样受体7对乳腺癌患者CD8+T细胞功能的影响[J].中华医学杂志,2019,99(20):1562-1566. 4 Byrne A,Savas P,Sant S,et al.Tissue-resident memory T cells in breast cancer control and immunotherapy responses[J].Nat Rev Clin Oncol,2020,17(6):341-348. 5 Baker KJ,Houston A,Brint E.IL-1 family members in cancer;two sides to every story[J].Front Immunol,2019,10:1197. 6 Diaz-Barreiro A,Huard A,Palmer G.Multifaceted roles of IL-38 in inflammation and cancer[J].Cytokine,2022,151:155808. 7 Andoh A,Nishida A.Pro- and anti-inflammatory roles of interleukin(IL)-33,IL-36,and IL-38 in inflammatory bowel disease[J].J Gastroenterol,2023,58(2):69-78. 8 Fulbright OJ,Forget MA,Haymaker C,et al.Isolation and maintenance of tumor-infiltrating lymphocytes for translational and clinical applications:established methods and new developments[J].Methods Mol Biol,2022,2435:43-71. 9 Wang Q,Ma L,An C,et al.The role of IL-38 in intestinal diseases - its potential as a therapeutic target[J].Front Immunol,2022,13:1051787. 10 Chen F,Zhang F,Tan Z,et al.Interleukin-38 in colorectal cancer:a potential role in precision medicine[J].Cancer Immunol Immunother,2020,69(1):69-79. 11 Dang J,He Z,Cui X,et al.The role of IL-37 and IL-38 in colorectal cancer[J].Front Med(Lausanne),2022,9:811025. 12 Huang L,Zhang H,Zhao D,et al.Interleukin-38 suppresses cell migration and proliferation and promotes apoptosis of colorectal cancer cell through negatively regulating extracellular signal-regulated kinases signaling[J].J Interferon Cytokine Res,2021,41(10):375-384. 13 Zhou H,Zhao Q,Yue C,et al.Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner[J].EMBO Rep,2022,23(6):e53791. 14 Dowling JP,Nikitin PA,Shen F,et al.IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation[J].MAbs,2023,15(1):2212673. 15 Kinoshita F,Tagawa T,Akamine T,et al.Interleukin-38 promotes tumor growth through regulation of CD8+Tumor-infiltrating lymphocytes in lung cancer tumor microenvironment[J].Cancer Immunol Immunother,2021,70(1):123-135. 16 Zöphel D,Angenendt A,Kaschek L,et al.Faster cytotoxicity with age:Increased perforin and granzyme levels in cytotoxic CD8+T cells boost cancer cell elimination[J].Aging Cell,2022,21(8):e13668. 17 Rodrigues LS,Barreto AS,Bomfim LGS,et al.Multifunctional,TNF-α and IFN-γ-secreting CD4 and CD8 T cells and CD8High T cells are associated with the cure of human visceral Leishmaniasis[J].Front Immunol,2021,12:773983. 18 Yang L,Shao X,Jia S,et al.Interleukin-35 dampens CD8+T cells activity in patients with non-viral hepatitis-related hepatocellular carcinoma[J].Front Immunol,2019,10:1032. 19 Liu MX,Liu QY,Liu Y,et al.Interleukin-35 suppresses antitumor activity of circulating CD8+T cells in osteosarcoma patients[J].Connect Tissue Res,2019,60(4):367-375. 20 Wang HM,Zhang XH,Ye LQ,et al.Insufficient CD100 shedding contributes to suppression of CD8+T-cell activity in non-small cell lung cancer[J].Immunology,2020,160(2):209-219. 21 Virassamy B,Caramia F,Savas P,et al.Intratumoral CD8+T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer[J].Cancer Cell,2023,41(3):585-601. 22 Bassez A,Vos H,Van Dyck L,et al.A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer[J].Nat Med,2021,27(5):820-832. |